Cohere Health Unveils Cohere Connect™ to Address Prior Authorization Compliance Gaps for Health Plans
Cohere delivers proven APIs to support CMS-0057-F interoperability compliance and end-to-end submission process support–from digitization and integration, through submission and response
BOSTON, Jan. 29, 2025 /PRNewswire/ -- Cohere Health®, a recognized leader in clinical intelligence, announces Cohere Connect™, offering health plans the tools and support to meet and exceed the prior authorization (PA) compliance mandates outlined in the Centers for Medicare & Medicaid Services (CMS) Interoperability and Prior Authorization Final Rule (CMS-0057-F). With Cohere Connect, providers can initiate the prior authorization process right from the provider EMR–reducing the provider burden and accelerating access to care for patients. Cohere Connect offers scalable APIs built to HL7® FHIR® standards, along with end-to-end process and integration support, addressing CMS requirements and their gaps.
Benefitting from Cohere's deep clinical and PA technology expertise, Cohere Connect goes beyond mandate specifications to address the unique complexities of prior authorization. With this offering, Cohere digitizes complex medical policies to address specialty and procedure-specific clinical guidelines, supporting an end-to-end prior authorization workflow. The APIs have supported six million submissions and offer providers intelligent guidance with workflow-based prompts and in-network checks to streamline processes. Cohere Connect also configures and connects to the required clinical and claims data needs based on line of business, procedure, diagnosis, place of service, and provider type to accelerate time to approval.
'Automated and expedited prior authorization is often more complex than it may appear,' notes Cohere Chief Product Officer, Matt Parker. 'Health plans need more than standards-based APIs to streamline processes and achieve faster decisions on care. Plans need to address system integration and policy digitization that go beyond the traditional API call and response. Using our years of experience in UM and PA automation–and our involvement in the Da Vinci Steering Committee–our solution addresses medical policies, as well as EMR, UM, claims, and other system integrations, to deliver a more complete solution.'
Cohere Connect helps health plans with the critical capabilities for their CMS-0057-F compliance needs including:
HL7 FHIR standards-based APIs supporting Da Vinci implementation guides, including:
Coverage Requirements Discovery (CRD) API, both highly configurable and scalable
Documentation Templates and Rules (DTR) API with support for thousands of policies
Prior Authorization Support (PAS) API, delivering smooth submission and response submissions
SMART® on FHIR app launched from the provider EMR to streamline documentation submission
Policy digitization, mapping, and management services
Developer documentation to support streamlined implementation
Cohere is unique in its comprehensive solutions for health plan prior authorization workflows beyond Cohere Connect. The company has achieved 96% digital platform adoption, and a provider NPS score of 64, through its AI-powered intelligent prior authorization platform and comprehensive clinical services. Cohere's portfolio delivers proven administrative efficiency, clinical quality, and medical expense savings.
To see a demo of Cohere Connect or Cohere's other capabilities, please contact us at https://coherehealth.com/connect/.
About Cohere Health, Inc.
Cohere Health is a clinical intelligence company delivering AI-powered intelligent prior authorization solutions, which streamlines patients' access to quality care by aligning their physicians and health plans for improved collaboration, transparency, and care coordination. Cohere works with nearly 600,000 providers and processes more than 12 million prior authorization requests annually, using AI to auto-approve up to 90% of requests for millions of health plan members around the country. The company was recognized twice in the Gartner™ Hype Cycle™ for U.S. Healthcare Payers, is a Top 5 LinkedIn™ Startup for 2023 & 2024, and is a three-time KLAS Points of Light award recipient. Its investors include Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners.
Contact:
Kat Long
anthonyBarnum Public Relations
Cohere Health
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
3 hours ago
- Miami Herald
GM claims No. 2 spot in US electric vehicle sales
General Motors Co. topped crosstown rival Ford Motor Co. to take the No. 2 spot in U.S. electric vehicle sales for the first five months of 2025. The Detroit automaker announced 62,000 EVs sold this year through May. Chevrolet carried sales among the company's brands, with 37,000 sold in the United States in that same period. Ford sold 34,132 EVs through May, according to the company. That represents a quarter drop year-over-year as sales of the F-150 Lightning pickup and E-Transit commercial van declined 42% and 93%, respectively. GM saw 94% year-over-year growth in domestic EV sales in the first quarter of 2025 and boasted more than 15% of U.S. EV market share. "Customers are responding in record numbers to our world-class portfolio of electric and gas-powered vehicles," Rory Harvey, executive vice president and president of global markets, said in a statement. "In the first two months of the second quarter, we more than doubled our EV sales compared to the same period last year." Part of the bump is attributable to price-conscious buyers worried about tariffs raising prices and legislative efforts to strip the $7,500 EV tax credit, said Sam Fiorani, vice president of AutoForecast Solutions LLC. "The idea that parts may be in short supply, costs may go up, all of these factors are weighing on the decision-making of buyers today," Fiorani said. "If they believe that they're going to need a vehicle in the next few months, a lot of them have moved to the dealership now to purchase while they believe the prices will be lower." GM still trails Tesla Inc. in EV sales, but CEO Elon Musk's dominance is waning in the face of domestic and Chinese competition. Tesla sold 1.3 million cars in the first quarter of 2025, a 9% decline from the year-earlier period, according to Bloomberg. Tesla's share of the U.S. EV market dropped from almost two-thirds to less than half in the past two years, according to Bloomberg reporting. Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.
Wall Street Journal
3 hours ago
- Wall Street Journal
Agency Overreach Leaves Patients Untreated
President Trump is pursuing deregulation to boost economic growth, but he could also use it to encourage medical innovation. As a first step, he could end the Coverage and Evidence Development program at the Centers for Medicare and Medicaid Services. CMS established the program two decades ago to speed Medicare coverage of new treatments that had been approved by the Food and Drug Administration. Instead, CED has slowed it down. In 2005 advances in medical devices were solving major medical problems, but CMS bureaucrats worried about taxpayer costs and demanded more data before covering them.
Yahoo
4 hours ago
- Yahoo
Micropolis Holding Company Filed Annual Report on Form 20-F for the Year Ended December 31, 2024
DUBAI, United Arab Emirates, June 10, 2025 (GLOBE NEWSWIRE) -- Micropolis Holding Company ('Micropolis' or the 'Company') (NYSE American: MCRP), a pioneer in unmanned ground vehicles and AI-driven security solutions, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission (the 'SEC') on May 8, 2025. The annual report on Form 20-F, which contains Micropolis' audited annual financial statements for the fiscal year ended December 31, 2024, can be accessed on the SEC's website at as well as via the Company's investor relations website at The Company will deliver a hard copy of its 2024 annual report on Form 20-F, including its complete audited financial statements, free of charge, to its shareholders upon written request to Fareed Aljawhari, Chief Executive Officer, at fareed@ About Micropolis Holding CompanyMicropolis is a UAE-based company specializing in the design, development, and manufacturing of unmanned ground vehicles (UGVs), AI systems, and smart infrastructure for urban, security, and industrial applications. The Company's vertically integrated capabilities cover everything from mechatronics and embedded systems to AI software and high-level autonomy. For more information please visit Forward-Looking StatementsThis press release contains 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as 'anticipate', 'estimate', 'expect', 'project', 'plan', 'intend', 'believe', 'may', 'will', 'should', 'can have', 'likely' and other words and terms of similar meaning. Forward-looking statements represent Micropolis' current expectations regarding future events and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other factors discussed in the 'Risk Factors' section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Investor Contact:KCSA Strategic CommunicationsValter Pinto, Managing DirectorPH: (212) 896-1254Valter@ Media Contact:Jessica Starmanmedia@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
